Congressional Research Service Reports - 62 Matching Results

Search Results

Results: 1 - 24 next
open access

The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

Description: This record provides information about The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents. Congressional interests in the cost of Pharmaceuticals have focused attention on several areas where the federal government has policies and programs.
Date: November 25, 2002
Creator: Schacht, Wendy H. & Thomas, John R.
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

Description: This record provides information about The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents. Congressional interests in the cost of Pharmaceuticals have focused attention on several areas where the federal government has policies and programs.
Date: January 16, 2003
Creator: Schacht, Wendy H. & Thomas, John R.
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

Description: This report describes the Proposed Legislative Changes Affecting Pharmaceutical Patents on the Hatch-Waxman Act. The Hatch-Waxman Act provides the FDA with certain authorities to offer periods of marketing for a pharmaceutical independent of the rights conferred by patents.
Date: May 8, 2003
Creator: Schacht, Wendy H. & Thomas, John R.
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

Description: This report describes the Proposed Legislative Changes Affecting Pharmaceutical Patents on Hatch-Waxman Act. The Hatch-Waxman Act provides the FDA with certain authorities to offer periods of marketing for a pharmaceutical independent of the rights conferred by patents.
Date: June 23, 2003
Creator: Schacht, Wendy H. & Thomas, John R.
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

Description: This report describes the Proposed Legislative Changes Affecting Pharmaceutical Patents on Hatch-Waxman Act. The Hatch-Waxman Act provides the FDA with certain authorities to offer periods of marketing for a pharmaceutical independent of the rights conferred by patents.
Date: June 30, 2003
Creator: Schacht, Wendy H. & Thomas, John R.
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

Description: This report describes the Proposed Legislative Changes Affecting Pharmaceutical Patents on Hatch-Waxman Act. The Hatch-Waxman Act provides the FDA with certain authorities to offer periods of marketing for a pharmaceutical independent of the rights conferred by patents.
Date: July 15, 2003
Creator: Schacht, Wendy H. & Thomas, John R.
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

Description: This report describes the Proposed Legislative Changes Affecting Pharmaceutical Patents on Hatch-Waxman Act. The Hatch-Waxman Act provides the FDA with certain authorities to offer periods of marketing for a pharmaceutical independent of the rights conferred by patents.
Date: September 17, 2003
Creator: Schacht, Wendy H. & Thomas, John R.
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

Description: This report describes the Proposed Legislative Changes Affecting Pharmaceutical Patents on Hatch-Waxman Act. The Hatch-Waxman Act provides the FDA with certain authorities to offer periods of marketing for a pharmaceutical independent of the rights conferred by patents.
Date: October 9, 2003
Creator: Schacht, Wendy H. & Thomas, John R.
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

Description: This record provides information about The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents. Congressional interests in the cost of Pharmaceuticals have focused attention on several areas where the federal government has policies and programs.
Date: January 5, 2004
Creator: Schacht, Wendy H. & Thomas, John R.
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
Back to Top of Screen